The Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly-Pivotal Fracture Trial ( HORIZON-PFT ) randomly assigned @ women aged @ to @ years to annual intravenous zoledronic acid or placebo for a mean follow-up of @ years .